Quarry LP’s Astria Therapeutics ATXS Stock Holding History

Quarry LP’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-188,988	Closed	-$2.47M	–	1457
2025 Q4	$2.47M	Buy	188,988 +187,271	+10,907%	+$2.24M	0.39%	37
2025 Q3	$12.5K	Buy	+1,717	New	+$11.6K	﹤0.01%	1613
2024 Q2	–	Sell	-2,000	Closed	-$28.1K	–	1795
2024 Q1	$28.1K	Buy	+2,000	New	+$24.9K	0.01%	756

Quarry LP's ATXS Position: Q1 2026 in Review

Quarry LP sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 188,988 shares — an estimated $2.47M sold.

Quarry LP first reported a position in ATXS in Q1 2024 and held it in 3 quarters. The position peaked at $2.47M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Quarry LP reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Quarry LP sold 188,988 Astria Therapeutics shares in Q1 2026, an estimated $2.47M.
Quarry LP first reported a position in Astria Therapeutics in Q1 2024 and held it in 3 quarters.
Quarry LP's Astria Therapeutics position peaked at $2.47M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.